DK0382381T3 - Behandling af leukocyt-dysfunktion med GM-CSF - Google Patents

Behandling af leukocyt-dysfunktion med GM-CSF

Info

Publication number
DK0382381T3
DK0382381T3 DK90300840.7T DK90300840T DK0382381T3 DK 0382381 T3 DK0382381 T3 DK 0382381T3 DK 90300840 T DK90300840 T DK 90300840T DK 0382381 T3 DK0382381 T3 DK 0382381T3
Authority
DK
Denmark
Prior art keywords
csf
dysfunction
treating
treatment
leukocyte
Prior art date
Application number
DK90300840.7T
Other languages
English (en)
Inventor
Eric M Bonnem
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK0382381T3 publication Critical patent/DK0382381T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
DK90300840.7T 1989-01-30 1990-01-26 Behandling af leukocyt-dysfunktion med GM-CSF DK0382381T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30439189A 1989-01-30 1989-01-30

Publications (1)

Publication Number Publication Date
DK0382381T3 true DK0382381T3 (da) 1993-07-12

Family

ID=23176323

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90300840.7T DK0382381T3 (da) 1989-01-30 1990-01-26 Behandling af leukocyt-dysfunktion med GM-CSF

Country Status (21)

Country Link
US (1) US5178855A (da)
EP (2) EP0382381B1 (da)
JP (1) JPH0651640B2 (da)
KR (1) KR0137361B1 (da)
AT (1) ATE89737T1 (da)
AU (1) AU633054B2 (da)
CA (1) CA2045605C (da)
DE (1) DE69001686T2 (da)
DK (1) DK0382381T3 (da)
ES (1) ES2055314T3 (da)
FI (1) FI913625A0 (da)
HK (1) HK46196A (da)
HU (1) HU207229B (da)
IE (1) IE64234B1 (da)
IL (1) IL93219A (da)
MY (1) MY105798A (da)
NZ (1) NZ243953A (da)
OA (1) OA09509A (da)
PT (1) PT92995B (da)
WO (1) WO1990008554A1 (da)
ZA (1) ZA90600B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2081104A1 (en) * 1991-02-22 1992-08-23 Glenn Pierce Use of gm-csf and g-csf to promote accelerated wound healing
GB9120304D0 (en) * 1991-09-24 1991-11-06 Erba Carlo Spa Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor
EP0661057A4 (en) * 1993-06-08 1997-09-03 Ajinomoto Kk ACCELERATOR OF THE PROLIFERATION OF HEMATOPIETIC CELLS.
AU704486B2 (en) * 1994-03-04 1999-04-22 Ludwig Institute For Cancer Research Animals with targeted gene disruption
US5942253A (en) 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
US6753165B1 (en) * 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US6911204B2 (en) 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology
CA2673049C (en) * 2006-12-22 2016-02-23 Novadel Pharma Inc. Stable anti-nausea oral spray formulations and methods
US7841878B2 (en) * 2007-08-09 2010-11-30 Haworth, Inc. Modular electrical distribution system for a building

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
AU606585B2 (en) * 1985-10-03 1991-02-14 Biogen, Inc. Human granulocyte-macrophage colony stimulating factor-like polypeptides and processes for producing them in high yields in microbial cells
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
WO1987003204A1 (en) * 1985-11-27 1987-06-04 Genetics Institute, Inc. Treatment of aids-type disease
AU606056B2 (en) * 1986-05-06 1991-01-31 Genetics Institute, Llc Production of m-csf
US5162111A (en) * 1986-07-30 1992-11-10 Grabstein Kenneth H Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor
EP0276846A3 (en) * 1987-01-29 1989-07-26 Zymogenetics, Inc. Colony-stimulating factor derivatives
WO1989004173A1 (en) * 1987-11-12 1989-05-18 Schering Corporation Acceleration of bone formation with gm-csf

Also Published As

Publication number Publication date
ATE89737T1 (de) 1993-06-15
MY105798A (en) 1995-01-30
EP0382381A1 (en) 1990-08-16
JPH0651640B2 (ja) 1994-07-06
IL93219A0 (en) 1990-11-05
ES2055314T3 (es) 1994-08-16
EP0455726A1 (en) 1991-11-13
EP0382381B1 (en) 1993-05-26
NZ243953A (en) 1997-06-24
CA2045605C (en) 1997-02-11
HUT57607A (en) 1991-12-30
DE69001686D1 (de) 1993-07-01
IL93219A (en) 1998-12-27
CA2045605A1 (en) 1990-07-31
KR910700069A (ko) 1991-03-13
PT92995B (pt) 1995-12-29
US5178855A (en) 1993-01-12
KR0137361B1 (ko) 1998-04-25
IE64234B1 (en) 1995-07-26
WO1990008554A1 (en) 1990-08-09
HK46196A (en) 1996-03-22
ZA90600B (en) 1990-10-31
JPH03504980A (ja) 1991-10-31
AU5048890A (en) 1990-08-24
HU207229B (en) 1993-03-29
DE69001686T2 (de) 1993-09-02
AU633054B2 (en) 1993-01-21
IE900318L (en) 1990-07-30
PT92995A (pt) 1990-07-31
OA09509A (en) 1992-11-15
FI913625A0 (fi) 1991-07-30

Similar Documents

Publication Publication Date Title
DE69333321D1 (de) Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten.
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
HUT63564A (en) Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine
DK0382381T3 (da) Behandling af leukocyt-dysfunktion med GM-CSF
EP0317568A4 (en) Use of stimulation of granulocyte-macrophage colonies for obtaining a medicament for the treatment of bacterial diseases.
ATE481135T1 (de) Kombinationstherapie mit omega-interferon zur behandlung von hepatitis c virus oder gelbfieber virus infektionen
KR870010871A (ko) 재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법
EP0397211A3 (en) Percutaneous administration of 3'-azide-3'-deoxythymidine
KR900701311A (ko) 재조합 사람 α-인터페론을 병소내로 투여하여 편평세포 암을 치료하는 방법
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.